Employing the IVW method, we detected no indications of an association between genetically predicted CRP levels and MPN risk, whether employing SNPs of genome-wide significance or those with a less stringent criterion (p-values of 0.109 and 0.134, respectively,Fig. 2). This evidence concerns the gene CRP and myeloproliferative disorder.